CXCL12 and breast cancer: Furthermore, the CAFs-s1 subtype in breast cancer enhances the recruitment and differentiation of CD4+CD25+ Treg in the TME through the CXCL12/SDF1-α pathway, thereby suppressing the function of effector T cells (33).